Keith Johnson
Sports Medicine · El Paso, TXNPI 1558369058
Payments from drug & device makers
Across 20 payments — averaging $762.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Fuse Medical, Inc.$13K
- Encore Medical, LP$1K
- Linvatec Corporation$801
- Medtronic$306
- Rattan And Associates$148
- Anika Therapeutics, Inc.$131
- plus $246 from 6 others
What the payments were for
- Consulting fees$12,50082%
- Travel & lodging$1,62511%
- Food & beverage$1,1227%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Fuse Medical, Inc. | 1 | $12,500 |
| Encore Medical, LP | 4 | $1,116 |
| Linvatec Corporation | 3 | $801 |
| Medtronic | 3 | $306 |
| Rattan And Associates | 2 | $148 |
| Anika Therapeutics, Inc. | 1 | $131 |
| Nalu Medical, Inc. | 1 | $127 |
| Smith+Nephew | 1 | $40 |
| Skeletal Dynamics Inc | 1 | $28 |
| CPM Medical Consultants, LLC | 1 | $23 |
| Pacira Pharmaceuticals Incorporated | 1 | $14 |
| Stryker | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$15,247 in reported general payments places this provider in the 75th percentile of 437 sports medicine providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Desonide | 59 | $36,199 |
| Clobetasol EmollientClobetasol Propionate/Emoll | 75 | $33,926 |
| Diclofenac Potassium | 35 | $31,149 |
| Diclofenac Sodium | 22 | $23,308 |
| Naproxen | 112 | $21,506 |
| Chlorzoxazone | 25 | $15,101 |
| Cyclobenzaprine Hcl | 106 | $7,384 |
| Clobetasol Propionate | 22 | $5,995 |
| XareltoRivaroxaban | 31 | $5,842 |
| Mometasone Furoate | 46 | $3,968 |
| Ibuprofen | 141 | $963 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 43 | $374 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 32 | $333 |
| Methylprednisolone | 33 | $309 |
| Celecoxib | 12 | $237 |
Paid to pharmacies, not to this prescriber.
Other sports medicine in El Paso
- Sergio AlvaradoEl Paso$376K
- Timothy VachrisAustin$5.7M
- Thomas DeberardinoSan Antonio$3.5M
- Mark HutchensAustin$2.5M
- Robert ScheinbergDallas$2.2M
- Marc LabbeThe Woodlands$2M
- Walter LoweHouston$1.4M
- Reed BartzSunnyvale$1.2M
- David BrownHouston$920K
- James GregoryHouston$848K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.